News in brief: Low dose pasireotide for Cushing’s disease; Thrombosis and vaccination advice for people with diabetes; Lockdown does not worsen glycaemic control

Low dose pasireotide for Cushing’s disease A lower dose of pasireotide may be effective in the long term management of Cushing’s disease and help minimise adverse effects, according to endocrinologists in Queensland. Dr Mimi Wong and colleagues at the Department of Diabetes and Endocrinology, Townsville University Hospital, report the case of a 60-year-old female whose ...

Already a member?

Login to keep reading.

© 2021 the limbic